首页> 外文学位 >Evaluation of transplacental pharmacology and toxicology from bench to bedside.
【24h】

Evaluation of transplacental pharmacology and toxicology from bench to bedside.

机译:从台到床评估胎盘的药理和毒理学。

获取原文
获取原文并翻译 | 示例

摘要

Many women require pharmacologic treatment during pregnancy. Clinical studies of drug safety in human pregnancy are often limited because of ethical considerations and thus a theoretical framework to evaluate drug safety in pregnancy is needed. Dual perfusion of a single placental lobule is the only experimental model to study human placental transfer of substances in organized placental tissue. The objectives of this thesis were to systematically evaluate the perfusion model in predicting placental drug transfer and to develop a model to account for non-placental pharmacokinetic parameters in the perfusion results. In general, the fetal-to-maternal drug concentration ratios matched well between placental perfusion experiments and in vivo samples taken at the time of delivery. After modeling for differences in maternal and fetal/neonatal protein binding and blood pH, the perfusion results were able to accurately predict in vivo transfer at steady state (R2 = 0.85, P < 0.0001). We then utilized the perfusion model to evaluate the placental transfer of 6-mercaptopurine (6-MP), a drug commonly used in pregnancy for the treatment of inflammatory bowel disease as well as the toxic effects of alcohol and formic acid on the placenta. Placental transfer of 6-MP is limited and binding to placental tissue and maternal pharmacokinetic parameters are the main factors that restrict placental transfer. Evaluation of the placental perfusion results together with our meta-analysis of clinical studies supported other evidence that the benefit of 6-MP outweighs any fetal risk when indicated. The placental transfer of folic acid was decreased in pregnancies with heavy alcohol exposure and folic acid supplementation may decrease the toxic effects of formic acid on the placenta. Furthermore, our validation of the ex vivo perfusion model showed that it is effective in predicting fetal exposure to drugs and should have a place in clinical and regulatory pharmacology and toxicology.
机译:许多妇女在怀孕期间需要药物治疗。由于道德方面的考虑,人类妊娠药物安全性的临床研究通常受到限制,因此需要一种评估妊娠药物安全性的理论框架。单个胎盘小叶的双重灌注是研究人胎盘在组织化胎盘组织中物质转移的唯一实验模型。本文的目的是系统评估灌注模型在预测胎盘药物转移中的作用,并建立一个模型来说明灌注结果中的非胎盘药代动力学参数。通常,胎盘与母体药物的浓度比在胎盘灌注实验与分娩时采集的体内样本之间非常吻合。在对母体和胎儿/新生儿蛋白质结合和血液pH的差异进行建模后,灌注结果能够准确预测稳态下的体内转移(R2 = 0.85,P <0.0001)。然后,我们利用灌注模型评估6-巯基嘌呤(6-MP)的胎盘转移,6-巯基嘌呤(6-MP)在妊娠中通常用于治疗炎症性肠病,以及酒精和甲酸对胎盘的毒性作用。 6-MP的胎盘转移受到限制,与胎盘组织的结合以及母体的药代动力学参数是限制胎盘转移的主要因素。胎盘灌注结果的评估以及我们对临床研究的荟萃分析支持了其他证据,表明使用6-MP的益处超过了任何胎儿风险。怀孕期间大量酒精暴露会减少叶酸的胎盘转移,补充叶酸可能会降低甲酸对胎盘的毒性作用。此外,我们对离体灌注模型的验证表明,该模型可有效预测胎儿对药物的接触,并应在临床和调节药理学和毒理学中占有一席之地。

著录项

  • 作者

    Hutson, Janine Rose.;

  • 作者单位

    University of Toronto (Canada).;

  • 授予单位 University of Toronto (Canada).;
  • 学科 Pharmacology.;Obstetrics.;Toxicology.
  • 学位 Ph.D.
  • 年度 2014
  • 页码 243 p.
  • 总页数 243
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号